The Behavioral Therapy for Primary Monosymptomatic Nocturnal Enuresis
NCT07015320
Behavior, Behavioral Symptoms
Giza, Egypt
View Trial DetailsNCT Number: NCT03543995
It is claimed that SBO may be responsible for bladder dysfunction in patients without known neurological disease. Subsequently, it was reported that the frequency of SBO in NE cases was higher than normal children. However, in controlled trials, SBO frequency was not different in NE patients compared to the normal population. Conversely, the incidence of dysfunctional bladder in the presence of SBO in NE patients was found to be higher and the response to treatment was worse than in non-SBO patients.
The present study aimed to determine whether the frequency of SBO in patients with NE was higher than in healthy subjects, the effect of SBO on the severity of LUTS and whether treatment response of primary NE patients changed in the presence of SBO.
Looking for future studies?
Notify Me6 year–15 year
All sexes
Observational
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 3 months
Patients were called for check-up one and three months later. When waking in the morning they were given a form to mark as dry or wet, and dry bed days were examined at check-up.
Ankara Training and Research Hospital
Other
The Relationship Between Nocturnal Enuresis And Spina Bifida Occulta: A Prospective Controlled Trial
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07015320
Behavior, Behavioral Symptoms
Giza, Egypt
View Trial DetailsNCT04413461
Behavior, Behavioral Symptoms
Cannes, France
View Trial DetailsNCT06772584
Behavior, Behavioral Symptoms
Cairo, State Or Province, Egypt
View Trial DetailsNCT06488976
Behavior, Behavioral Symptoms
Istanbul, Turkey (Türkiye)
View Trial Details